Ujjin Anunya, Wongcharoen Wanwarang, Suwanagool Arisara, Chai-Adisaksopha Chatree
Division of Medicine, Neurological Institute of Thailand, Bangkok 10400, Thailand.
Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 52000, Thailand.
J Clin Med. 2024 May 2;13(9):2675. doi: 10.3390/jcm13092675.
: Warfarin has been the mainstay treatment for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation (AF). The optimal starting dose of warfarin remains unclear. : To investigate the most optimal dosing strategies for warfarin starting dose in Thai patients with AF. : We enrolled consecutive AF patients who were starting on warfarin and resulting in a stable INR of 2.0-3.0 at two consecutive time points. We measured the dose of warfarin at which INR achieved the target range. The optimal dosage was defined as the difference from the actual dose within 20%. We compared strategies of warfarin dosing, including warfarin dosing formula, 2.5 mg, 3 mg and 5 mg doses. The primary endpoints were the proportions of patients in optimal, underdosing, and overdosing categories. : Among 1207 patients visiting the Outpatient Clinic between October 2011 and September 2021, 531 patients were identified with AF and INR in the therapeutic range of 2.0-3.0 on at least two consecutive visits. The mean age of participants was 68 ± 11 years, and men accounted for 44.4% of the population. The warfarin dosing formula resulted in optimal dosing in 37% and overdosing in 24% of cases, whereas the 2.5 mg, 3 mg and 5 mg doses resulted in optimal dosing in 36%, 39%, and 11%, and overdosing in 33%, 44% and 88% of patients, respectively ( < 0.01). : In Thai patients with AF, the optimal warfarin starting dose may be 2.5 mg, 3 mg or a simplified warfarin dosing formula, whereas the 5 mg dose should be avoided due to the high risk of overdosing.
华法林一直是预防心房颤动(AF)患者中风和全身性血栓栓塞的主要治疗药物。华法林的最佳起始剂量仍不明确。
研究泰国AF患者华法林起始剂量的最优化给药策略。
我们纳入了连续使用华法林且在两个连续时间点国际标准化比值(INR)稳定在2.0 - 3.0的AF患者。我们测量了INR达到目标范围时的华法林剂量。最佳剂量定义为与实际剂量相差在20%以内。我们比较了华法林给药策略,包括华法林给药公式、2.5毫克、3毫克和5毫克剂量。主要终点是处于最佳剂量、剂量不足和剂量过量类别的患者比例。
在2011年10月至2021年9月期间到门诊就诊的1207例患者中,531例患者被确诊为AF且至少连续两次就诊时INR在2.0 - 3.0的治疗范围内。参与者的平均年龄为68±11岁,男性占人群的44.4%。华法林给药公式在37%的病例中导致最佳剂量,在24%的病例中导致剂量过量,而2.5毫克、3毫克和5毫克剂量分别在36%、39%和11%的患者中导致最佳剂量,在33%、44%和88%的患者中导致剂量过量(P<0.01)。
在泰国AF患者中,华法林的最佳起始剂量可能是2.5毫克、3毫克或简化的华法林给药公式,而5毫克剂量因剂量过量风险高应避免使用。